The Metabolic Signature of AML Cells Treated With Homoharringtonine

The Metabolic Signature of AML Cells Treated With Homoharringtonine

Acute myeloid leukemia (AML) is a hematologic malignancy. The overall prognosis is poor and therapeutic strategies still need to be improved. Studies have found that abnormalities in metabolisms promote the survival of AML cells. In recent years, an increasing number of studies have reported the eff...

Full description

Bibliographic Details
Main Authors: Yulong Zhang, Na Li, Zhiguang Chang, Huabin Wang, Hanzhong Pei, Dengyang Zhang, Qi Zhang, Junbin Huang, Yao Guo, Yuming Zhao, Yihang Pan, Chun Chen, Yun Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
homoharringtonine
AML
ether lipid metabolism
RNA-seq
choline metabolism
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.931527/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.931527/full

Similar Items